These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 33262760)

  • 41. Endothelial dysfunction and vascular stiffness in systemic lupus erythematosus: Are they early markers of subclinical atherosclerosis?
    Zardi EM; Afeltra A
    Autoimmun Rev; 2010 Aug; 9(10):684-6. PubMed ID: 20553974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells.
    Thacker SG; Duquaine D; Park J; Kaplan MJ
    Lupus; 2010 Mar; 19(3):288-99. PubMed ID: 20068018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Type I Interferon-Activated STAT4 Regulation of Follicular Helper T Cell-Dependent Cytokine and Immunoglobulin Production in Lupus.
    Dong X; Antao OQ; Song W; Sanchez GM; Zembrzuski K; Koumpouras F; Lemenze A; Craft J; Weinstein JS
    Arthritis Rheumatol; 2021 Mar; 73(3):478-489. PubMed ID: 33512094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
    Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of BAFF Neutralization on Atherosclerosis Associated With Systemic Lupus Erythematosus.
    Saidoune F; Even G; Lamri Y; Chezel J; Gaston AT; Escoubet B; Papo T; Charles N; Nicoletti A; Sacre K
    Arthritis Rheumatol; 2021 Feb; 73(2):255-264. PubMed ID: 32783382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Role of neutrophil dysfunction in the pathogenesis of systemic lupus erythematosus].
    Smirnova EV; Krasnova TN; Proskurnina EV; Mukhin NA
    Ter Arkh; 2017; 89(12):110-113. PubMed ID: 29411769
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circulating endothelial cells as a marker of vascular dysfunction in patients with systemic lupus erythematosus by real-time polymerase chain reaction.
    Attia FM; Maaty A; Kalil FA
    Arch Pathol Lab Med; 2011 Nov; 135(11):1482-5. PubMed ID: 22032577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers.
    Chasset F; Ribi C; Trendelenburg M; Huynh-Do U; Roux-Lombard P; Courvoisier DS; Chizzolini C;
    Rheumatology (Oxford); 2020 Nov; 59(11):3468-3478. PubMed ID: 32375176
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endothelial Dysfunction in Systemic Lupus Erythematosus: Pathogenesis, Assessment and Therapeutic Opportunities.
    Mauro D; Nerviani A
    Rev Recent Clin Trials; 2018; 13(3):192-198. PubMed ID: 29542419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. B lymphocyte stimulator modulates number and function of endothelial progenitor cells in systemic lupus erythematosus.
    Spinelli FR; Barbati C; Cecarelli F; Morello F; Colasanti T; Vomero M; Massaro L; Orefice V; Alessandri C; Valesini G; Conti F
    Arthritis Res Ther; 2019 Nov; 21(1):245. PubMed ID: 31752963
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    Toral M; Robles-Vera I; Romero M; de la Visitación N; Sánchez M; O'Valle F; Rodriguez-Nogales A; Gálvez J; Duarte J; Jiménez R
    FASEB J; 2019 Sep; 33(9):10005-10018. PubMed ID: 31173526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
    Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
    Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic lupus erythematosus: all roads lead to type I interferons.
    Pascual V; Farkas L; Banchereau J
    Curr Opin Immunol; 2006 Dec; 18(6):676-82. PubMed ID: 17011763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The DNA sensors AIM2 and IFI16 are SLE autoantigens that bind neutrophil extracellular traps.
    Antiochos B; Trejo-Zambrano D; Fenaroli P; Rosenberg A; Baer A; Garg A; Sohn J; Li J; Petri M; Goldman DW; Mecoli C; Casciola-Rosen L; Rosen A
    Elife; 2022 May; 11():. PubMed ID: 35608258
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atherosclerosis in systemic lupus erythematosus.
    Sherer Y; Zinger H; Shoenfeld Y
    Autoimmunity; 2010 Feb; 43(1):98-102. PubMed ID: 20014976
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Type I interferons promote the survival and proinflammatory properties of transitional B cells in systemic lupus erythematosus patients.
    Liu M; Guo Q; Wu C; Sterlin D; Goswami S; Zhang Y; Li T; Bao C; Shen N; Fu Q; Zhang X
    Cell Mol Immunol; 2019 Apr; 16(4):367-379. PubMed ID: 29563616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel endothelial progenitor cells populations as biomarkers of damage and remission in systemic lupus erythematosus.
    Rafael-Vidal C; Martínez-Ramos S; Malvar-Fernández B; Altabás-González I; Mouriño C; Pazos-López P; Fraga-Bau A; Pego Reigosa JM; García S
    Arthritis Res Ther; 2024 Sep; 26(1):170. PubMed ID: 39342288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis.
    Thacker SG; Zhao W; Smith CK; Luo W; Wang H; Vivekanandan-Giri A; Rabquer BJ; Koch AE; Pennathur S; Davidson A; Eitzman DT; Kaplan MJ
    Arthritis Rheum; 2012 Sep; 64(9):2975-85. PubMed ID: 22549550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus.
    Yu SL; Kuan WP; Wong CK; Li EK; Tam LS
    Clin Dev Immunol; 2012; 2012():715190. PubMed ID: 22312407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
    Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C
    Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.